AU2003211398A1 - Markers for predicting pathological conditions in haert failure and method of using the same - Google Patents

Markers for predicting pathological conditions in haert failure and method of using the same

Info

Publication number
AU2003211398A1
AU2003211398A1 AU2003211398A AU2003211398A AU2003211398A1 AU 2003211398 A1 AU2003211398 A1 AU 2003211398A1 AU 2003211398 A AU2003211398 A AU 2003211398A AU 2003211398 A AU2003211398 A AU 2003211398A AU 2003211398 A1 AU2003211398 A1 AU 2003211398A1
Authority
AU
Australia
Prior art keywords
haert
markers
failure
same
pathological conditions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003211398A
Inventor
Masanori Asakura
Hidehiko Furukawa
Tadashi Isomura
Masafumi Kitakaze
Ryuta Koishi
Kenji Nakamaru
Seiji Takashima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Publication of AU2003211398A1 publication Critical patent/AU2003211398A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2003211398A 2002-02-28 2003-02-27 Markers for predicting pathological conditions in haert failure and method of using the same Abandoned AU2003211398A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2002/54388 2002-02-28
JP2002054388 2002-02-28
JP2002112228 2002-04-15
JP2002/112228 2002-04-15
PCT/JP2003/002228 WO2003072824A1 (en) 2002-02-28 2003-02-27 Markers for predicting pathological conditions in haert failure and method of using the same

Publications (1)

Publication Number Publication Date
AU2003211398A1 true AU2003211398A1 (en) 2003-09-09

Family

ID=27767203

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003211398A Abandoned AU2003211398A1 (en) 2002-02-28 2003-02-27 Markers for predicting pathological conditions in haert failure and method of using the same

Country Status (3)

Country Link
AU (1) AU2003211398A1 (en)
TW (1) TW200304948A (en)
WO (1) WO2003072824A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005095985A1 (en) * 2004-03-19 2005-10-13 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with endothelin type b receptor-like protein 2 (etbr-lp-2)
DE102004024617A1 (en) * 2004-05-18 2005-12-29 Ganymed Pharmaceuticals Ag Differentially expressed in tumors gene products and their use
ES2401233T3 (en) * 2007-10-17 2013-04-18 Universidad de Córdoba Isoforms of the human somatostatin type 5 receptor produced by alternative treatment and oligonucleotide pairs for their detection by PCR

Also Published As

Publication number Publication date
TW200304948A (en) 2003-10-16
WO2003072824A1 (en) 2003-09-04

Similar Documents

Publication Publication Date Title
AU2003270843A1 (en) System and method for assessing fluid distribution
AU2003206396A1 (en) Systems and methods for predicting disease behavior
AU2003265190A1 (en) Methods and systems for improved boundary contrast
AU2003278801A1 (en) Noninvasive nonlinear systems and methods for predicting seizure
IL163604A0 (en) Method and system for assessing eyedisease
HK1082055A1 (en) Electrophoretic medium and method for forming the same
AU2003220546A1 (en) System and method for biopsy management
AU2003243646A1 (en) System and method for facilitating ridesharing
AU2003298667A1 (en) Servicer compensation system and method
AU2003212608A1 (en) System and method for assessing and indicating the health of components
AUPS017302A0 (en) Performance monitoring system and method
AU2003268369A1 (en) Performance monitor and method therefor
AU2003234794A1 (en) Composition and method for temporarily fixing solid
EP1475766A4 (en) Identifying medium and identifying method for object
AU2003256710A1 (en) Auto-stimulating cells and method for making and using the same
AU2003233865A1 (en) Electrolysis cell and method
AU2003247051A1 (en) System and method for segmenting
AU2003270578A1 (en) Interconnection architecture and method of assessing interconnection architecture
AU2002351206A1 (en) Lateral lubistor structure and method
WO2003075169A8 (en) Method and system for the automatic planning of experiments
AU2003212404A1 (en) Method and arrangement for assembly
AU2003282815A1 (en) Method and system for detailed construction estimating
AU2003249537A1 (en) Defect area management
AU2003226145A1 (en) Gauge and method
AU2003211398A1 (en) Markers for predicting pathological conditions in haert failure and method of using the same

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase